| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Counted by filing, the last 12 months brought 2 open-market purchases by 2 insiders worth about $19K and no sales. The 12 months before that brought 3 open-market purchases by 2 insiders worth about $50K and no sales.
The largest open-market purchase in the last two years was 3,360 shares by Michael Richard Feldschuh (Chief Executive Officer) at an average $7.68 on March 10, 2025, about $26K. Twelve months later DXR was up 48%.
The most recent purchase was by Michael Richard Feldschuh (Chief Executive Officer) on April 8, 2026.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 243.7K | $2.17M | - | |
| Other | 78.9K | $702.3K | - | |
| CFO | 33.0K | $294.1K | - | |
| Other | 26.0K | $231.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 8, 2026 | Michael Richard Feldschuh75 | Chief Executive Officer | Buy | 1,000 | $9.07 | $9,070.00 | +0.5% | +15.6% | - | |
| Mar 31, 2026 | Robert J Michel62 | Chief Financial Officer | Buy | 1,000 | $9.90 | $9,900.00 | +5.0% | +4.6% | - | |
| Mar 20, 2026 | John Jefferies | Chief Medical Officer | Buy | 5,941 | $0.00 | - | +33.7% | -10.9% | - | |
| Dec 9, 2025 | Jonathan Adam Feldschuh | Chief Scientific Officer | Buy | 18,000 | $0.00 | - | +50.1% | -9.6% | - | |
| Dec 9, 2025 | Robert J Michel62 | Chief Financial Officer | Buy | 3,000 | $0.00 | - | +17.6% | -9.6% | - | |
| Nov 12, 2025 | John Jefferies | Chief Medical Officer | Buy | 2,344 | $0.00 | - | +15.3% | -2.6% | - | |
| Apr 4, 2025 | Michael Richard Feldschuh75 | Chief Executive Officer | Buy | 2,063 | $7.89 | $16,277.07 | +1.0% | +28.7% | +18.1% | |
| Mar 10, 2025 | Robert J Michel62 | Chief Financial Officer | Buy | 1,000 | $8.00 | $8,000.00 | +6.2% | +19.4% | +48.2% | |
| Mar 10, 2025 | Michael Richard Feldschuh75 | Chief Executive Officer | Buy | 3,360 | $7.68 | $25,804.80 | +1.6% | +19.4% | +48.2% | |
| Dec 6, 2024 | Jonathan Adam Feldschuh | Chief Scientific Officer | Buy | 32,000 | $0.00 | - | +818.8% | -12.6% | +44.5% |